Benjamin Gartrell, MD
Internal Medicine · Bronx, NYNPI 1043414451
Payments from drug & device makers
Across 1,321 payments — averaging $4731.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.4M
- Novartis$1.3M
- Janssen Research & Development, LLC$765K
- Bayer$519K
- Blue Earth Diagnostics$487K
- AstraZeneca$247K
- plus $1.5M from 26 others
Across 3 payments — averaging $1603.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5K
- Regeneron$212
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 138 | $1,426,220 |
| Novartis | 17 | $1,302,597 |
| Janssen Research & Development, LLC | 436 | $764,755 |
| Bayer | 169 | $518,511 |
| Blue Earth Diagnostics | 52 | $486,869 |
| AstraZeneca | 8 | $246,883 |
| Regeneron | 69 | $237,840 |
| Astrazeneca UK Limited | 4 | $206,331 |
| E.r. Squibb & Sons, L.L.C. | 23 | $156,782 |
| Genentech, Inc. | 38 | $155,050 |
| G1 Therapeutics, Inc. | 56 | $106,197 |
| Exelixis Inc. | 62 | $90,660 |
| Taiho Oncology, Inc. | 40 | $88,906 |
| Astellas Pharma Global Development | 39 | $64,168 |
| Ferring Pharmaceuticals AS | 26 | $60,700 |
| Amgen | 2 | $59,765 |
| Eisai Inc. | 41 | $54,983 |
| Gilead | 13 | $52,928 |
| EMD Serono, Inc. | 13 | $40,229 |
| Ferring International Pharmascience Center US | 14 | $34,286 |
| Merck | 21 | $31,748 |
| Janssen Global Services, LLC | 14 | $20,770 |
| Eli Lilly | 1 | $15,185 |
| Sanofi | 2 | $12,088 |
| Johnson & Johnson | 10 | $6,139 |
| Janssen Scientific Affairs, LLC | 6 | $4,846 |
| Astellas Pharma US Inc | 1 | $2,340 |
| AVEO Pharmaceuticals, Inc. | 2 | $1,603 |
| Seagen Inc. | 1 | $1,150 |
| Genentech USA, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$6,250,575 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Bronx
- David SteinBronx$2.4M
- Haiying ChengBronx$1.7M
- Jason LeiderBronx$1.4M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.